Meridian Bioscience Statistics Share Statistics Meridian Bioscience has 43.83M
shares outstanding. The number of shares has increased by 1.15%
in one year.
Shares Outstanding 43.83M Shares Change (YoY) 1.15% Shares Change (QoQ) 0.58% Owned by Institutions (%) n/a Shares Floating 41.15M Failed to Deliver (FTD) Shares 4 FTD / Avg. Volume n/a
Short Selling Information The latest short interest is 4.47M, so 0% of the outstanding
shares have been sold short.
Short Interest 4.47M Short % of Shares Out n/a Short % of Float 10.36% Short Ratio (days to cover) 3.38
Valuation Ratios The PE ratio is 32.68 and the forward
PE ratio is null.
Meridian Bioscience's PEG ratio is
-0.8.
PE Ratio 32.68 Forward PE n/a PS Ratio 4.17 Forward PS n/a PB Ratio 3.77 P/FCF Ratio 18.82 PEG Ratio -0.8
Financial Ratio History Enterprise Valuation Meridian Bioscience has an Enterprise Value (EV) of 1.34B.
EV / Sales 4.02 EV / EBITDA 18.57 EV / EBIT 16.24 EV / FCF 18.13
Financial Position The company has a current ratio of 3.63,
with a Debt / Equity ratio of 0.08.
Current Ratio 3.63 Quick Ratio 2.46 Debt / Equity 0.08 Debt / EBITDA 0.43 Debt / FCF 0.42 Interest Coverage 46.68
Financial Efficiency Return on Equity is 11.54% and Return on Invested Capital is 10.66%.
Return on Equity 11.54% Return on Assets 9.17% Return on Invested Capital 10.66% Revenue Per Employee $482.63K Profits Per Employee $61.53K Employee Count 690 Asset Turnover 0.72 Inventory Turnover 2.13
Taxes Income Tax 11.86M Effective Tax Rate 21.83%
Stock Price Statistics The stock price has increased by 0% in the
last 52 weeks. The beta is 0, so Meridian Bioscience's
price volatility has been lower than the market average.
Beta 0 52-Week Price Change n/a 50-Day Moving Average 32.89 200-Day Moving Average 31.01 Relative Strength Index (RSI) 71.24 Average Volume (20 Days) 686,607
Income Statement In the last 12 months, Meridian Bioscience had revenue of 333.02M
and earned 42.46M
in profits. Earnings per share was 0.96.
Revenue 333.02M Gross Profit 188.36M Operating Income 55.51M Net Income 42.46M EBITDA 72.02M EBIT 55.51M Earnings Per Share (EPS) 0.96
Full Income Statement Balance Sheet The company has 81.45M in cash and 30.96M in
debt, giving a net cash position of 50.5M.
Cash & Cash Equivalents 81.45M Total Debt 30.96M Net Cash 50.5M Retained Earnings 223.16M Total Assets 456.76M Working Capital 122.96M
Full Balance Sheet Cash Flow In the last 12 months, operating cash flow was 82.36M
and capital expenditures -8.62M, giving a free cash flow of 73.75M.
Operating Cash Flow 82.36M Capital Expenditures -8.62M Free Cash Flow 73.75M FCF Per Share 1.68
Full Cash Flow Statement Margins Gross margin is 56.56%, with operating and profit margins of 16.67% and 12.75%.
Gross Margin 56.56% Operating Margin 16.67% Pretax Margin 16.31% Profit Margin 12.75% EBITDA Margin 21.63% EBIT Margin 16.67% FCF Margin 22.14%
Dividends & Yields VIVO pays an annual dividend of $0.62,
which amounts to a dividend yield of 3.18%.
Dividend Per Share $0.62 Dividend Yield 3.18% Dividend Growth (YoY) 0% Payout Ratio 38.8% Earnings Yield 3.06% FCF Yield 5.31%
Dividend Details Analyst Forecast Currently there are no analyst rating for VIVO.
Price Target n/a Price Target Difference n/a Analyst Consensus n/a Analyst Count n/a
Stock Forecasts Fair Value There are several formulas that can be used to estimate the
intrinsic value of a stock.
Lynch Fair Value $10.92 Lynch Upside -67.85% Graham Number 13.47 Graham Upside -60.35%
Stock Splits The last stock split was on May 14, 2007. It was a
forward
split with a ratio of 3:2.
Last Split Date May 14, 2007 Split Type forward Split Ratio 3:2
Scores Altman Z-Score 9.28 Piotroski F-Score 3
